Key result
Researchers evaluate FDA-mandated device postapproval studies for the availability and public dissemination of clinical results.
Key points are not available for this paper at this time.
Incomplete dissemination of FDA-mandated postapproval device results may limit clinical decisions; leaves open needs for stronger regulatory transparency.
Conducted for The ABIM Foundation by PerryUndem Research/Communication (Accessed August 9, 2014 at http://www.choosingwisely.
No takes yet. Share an insight, caveat, or question.
Quesada et al. (2016) studied this question. FDA-mandated postapproval studies for medical devices were assessed for the availability and public dissemination of their clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: